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Nannochloropsis  oculata  is  a marine-water  microalgae  that  is  considered  to be a  good  source
of omega-3  fatty  acids,  speciﬁcally  eicosapentaenoic  acid (EPA),  utilized  in the  production
of  an  omega-3  oil for use as  a  dietary  supplement.  This  study  investigates  the  safety  of
N.  oculata  in male  and  female  Sprague-Dawley  rats  administered  a 0 or 10  mL/kg  bw/rat
N. oculata  (10E8  viable  cells/mL)  suspension  by oral  gavage  once  daily  for 14 consecutive
days.  No mortalities  occurred  and  no  signs  of toxicity  were  observed  during  the study.  No
treatment-related  effects  were  seen  for body  weight,  food  consumption,  urinalysis,  clinical
chemistry, hematology,  gross  pathology,  organ  weights,  or histopathology.  Although  sta-mega-3
icosapentaenoic acid
lgae
PA
at
tistically signiﬁcant  effects  were  noted  for some  endpoints,  none  were  considered  to  be  of
toxicological  signiﬁcance.  The  N. oculata  suspension  was concluded  to have  no  toxicity  in
rats,  conﬁrming  that  the  algal  strain  used  in  the  production  of  omega-3  oil  is  not  pathogenic
when  administered  orally  to  rats.
©  2015  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under. Introduction
Nannochloropsis oculata is a marine-water single-celled
lgae of the Eustigmatophyceae class. It is one of six species
f algae found in the genus Nannochloropsis and was  origi-
ally isolated off the coast of Scotland [1]. Nannochloropsis
p. has been utilized as a food source in aquaculture, pro-
iding a source of omega-3 fatty acids [2]. Recently a N.
culata-derived oil has been determined safe for use in
ietary supplements [3]. Furthermore, the nutritional eval-
ation of a Nannochloropsis sp. found it to have high levels
f protein, polyunsaturated fatty acids, and antioxidant
igments [4]. The algae is described as a phototrophic
nicellular, non-zoospore producing, free-ﬂoating algae
aving a diameter of 2–4 m,  growing non-axenically in
∗ Corresponding author at: Qualitas Health Ltd., 19 Hartom St.,
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a temperature of 11–16 ◦C. The cells contain yellow-green
parietal chloroplasts [1,2].
The 14-day toxicity study was performed under Good
Laboratory Practice (GLP) conditions according to the OECD
[5] guidelines for the testing of chemicals. The suspension
containing N. oculata was  tested orally in rats to assess its
toxicity and/or pathogenicity according to a modiﬁed study
of the guidelines of OPPTS 885.3050.
2. Materials and methods
2.1. Test item
N. oculata suspension (Lot No. 91020140001; Qualitas
Health Inc.) is a green-colored suspension of microalgae.
The source biomass, N. oculata, was grown in shallow,
open-air, plastic-lined ponds in a proprietary growth
medium consisting of food grade plant fertilizers and
nutrients [4]. The algae was harvested and suspended
in deionized water resulting in a live algal biomass
(w/w%) of <0.2% in deionized water. Toxin analyses
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oxicology Reports 2 (2015) 617–623
Table 1
Concentration of viable algal cells during treatment.
Treatment day Cell count (viable algal
cells/mL)
1 1.21 × 10E08
2  1.28 × 10E08
3  1.32 × 10E08
4  1.25 × 10E08
5  1.27 × 10E08
6  1.14 × 10E08
7  1.18 × 10E08
8  1.23 × 10E08
9  1.12 × 10E08
10  1.15 × 10E08
11  1.10 × 10E08
12  1.16 × 10E08618 M.L. Kagan, R.A. Matulka / T
conducted on N. oculata indicated that no natural prod-
uct toxins were detected above detection limits including
microcystins/nodularin, anatoxin-a, cylindrospermopsin,
paralytic shellﬁsh toxin/saxitoxins, okadaic acid and breve-
toxins & domoic acid [6]. The N. oculata suspension was
prepared by Qualitas Health Inc. and supplied to the lab
for testing as viable cultures. The suspension was stored by
refrigeration (2–8 ◦C).
2.2. Animals and housing
A total of 40 (20 male and 20 female) 7–8 week old
Sprague-Dawley rats bred in-house by Advinus Thera-
peutics Ltd. (Bangalore, India) were housed in standard
polysulfone cages (2/cage) with stainless steel top grills.
Steam sterilized corn cob was used as bedding and changed
along with the cage twice a week. Cages were placed on
ﬁve-tier rack. The animals were acclimatized for 5 days
prior to the start of treatment. Initial mean group body
weights ranged from 189 to 191 g for the male rats and
153 to 155 g for the female rats. Room temperature was
maintained at 20–24 ◦C with a relative humidity of 65–67%,
a minimum of 13.7 air changes/h and a 12 h light and 12 h
dark cycle. Filtered deep-bore well water and Teklad Global
14% protein rodent maintenance diet (Harlan Laboratories,
An Venray, The Netherlands) were provided ad libitum.
Animal handling was performed according to the require-
ments of the Association for Assessment and Accreditation
of Laboratory Animal Care (AAALAC).
2.3. Experimental design
The potential toxicity or pathogenicity of a microor-
ganism is generally assessed in accordance with the US
Environmental Protection Agency Microbial Pesticide Test
Guidelines OPPTS 885.3030 during which the survival and
propagation of the microorganism in the rat are evaluated
by culturing tissue samples, blood, and feces following a
single high exposure and an adequate post-exposure obser-
vation period [7]. For the current study, the purpose was
not only to determine whether or not the microorganism
was toxic in its natural state, but to also determine its toxic-
ity in the rat following ingestion. Furthermore, the current
study was designed to determine if the organism could
manage to replicate itself in organs and tissue of the host
and eventually become a danger to the health of the animal.
However, since N. oculata is a phototropic vegetable species
and typically does not replicate without the presence of
light, a modiﬁed version of the OPPTS study protocol is used
that removed the steps to culture algae in tissue samples by
using a 14-day oral administration of the test item to rats
to provide information on its toxicity and pathogenicity.
Two groups of Sprague-Dawley rats (n = 10 rats/
sex/group) were administered (via oral gavage) 0 and
10 mL/kg N. oculata suspension (providing a minimum
of 10E8 viable cells/animal) respectively, once daily for
14 days. Vehicle control animals were administered by
puriﬁed water. In order to determine the concentration of
viable algal cells, 1 mL  of the test material was evaluated
daily and the algal cell counts were determined using a
haemocytometer. Dead cells were identiﬁed by their loss13  1.20 × 10E08
14  1.16 × 10E08
of chlorophyll and were excluded from the cell count.
There were no dead cells observed during the cell counts.
The concentrations of viable algal cells in the N. oculata
suspension were in the range of 1.10 × 10E8 to 1.32 × 10E8
viable algal cells/mL throughout the study (Table 1). Doses
were administered using disposable plastic syringes,
attached with a stainless steel metal feeding cannula. Fol-
lowing the treatment period, all animals were sacriﬁced
on day 15.
Rats were observed twice daily for signs of morbidity
and mortality and clinical signs until study termination.
The food was  analyzed and found to be below estab-
lished maximum levels for heavy metals, mycotoxins
(Aﬂatoxin B1, B2, G1 and G2), chlorinated hydrocarbons
and organophosphates. The food was composed mainly of
14% protein, 4% fat and 4% ﬁber, as is typical for diets for
this species and strain of rat. Drinking water was  analyzed
and found acceptable as a potable water source for the
area (Bangalore, India). Body weights were recorded on day
1 prior to the test item administration and on days 4, 7,
11, and 14. Fasting body weights were recorded prior to
necropsy on day 15. Food consumption was  measured on
days 4, 7, 11, and 14. At the end of the study, rats were fasted
overnight (water allowed), anaesthetized with isoﬂurane,
and exsanguinated.
Blood was collected from the retro-orbital sinus plexus
with ﬁne capillary tubes. An aliquot of blood was  collected
in tubes containing 3.2% sodium citrate solution for deter-
mination of coagulation parameters and the remaining
blood was collected into k2EDTA and lithium heparinized
tubes for hematology and clinical chemistry examinations.
Prior to sacriﬁce, urine was  collected in urine collection
tubes for all rats. Each rat was placed in specially fabricated
cages overnight (water allowed) and the next morning (day
18) the urine was collected for analysis. Urinalysis param-
eters examined in the collected samples included color,
clarity, bilirubin, glucose, ketone bodies, nitrite, proteins,
pH, speciﬁc gravity, urobilinogen, and volume. Urine was
also subjected to microscopic examination for sediments
such as crystals, epithelial cells, erythrocytes, leukocytes
and casts.
All animals were fasted overnight prior to terminal
sacriﬁce on day 19. At the scheduled termination, all
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Table  2
Tissue collection and organ weighing.
Organ/tissue Organ/tissue Organ/tissue
Adrenal glandsa Ileum with Peyer’s patches Seminal vesicles and
All  gross lesions Jejunum coagulating glandsa
Aorta Kidneysa Skeletal muscle
Bone marrow smear Livera Skin
Brain (cerebrum, cerebellum and medulla oblongata/pons)a Lungs Spinal cord (cervical, thoracic, lumbar
Cecum Mammary gland Spleena
Colon Mesenteric lymph nodes Sternum with marrow
Duodenum Esophagus Stomach
Epididymidesa Ovariesa Testesa
Esophagus Pancreas Thymusa
Eyes with optic nerve Pituitarya Thyroid with Parathyroidsa
Femur bone with joint Prostatea Trachea
Hearta Rectum Urinary bladder
Salivary glands Uterus with cervix
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*a Weighed organs.
ats were euthanized by exsanguination under isoﬂu-
ane anesthesia. The organs identiﬁed in Table 2 were
emoved, weighed and/or examined for gross pathological
nomalies. Histopathological examinations were carried
ut on the preserved organs of both treated and control
ats.
Data were captured using ProvantisTM, a toxicology data
apture system. Parameters such as body weight, net body-
eight gains, food consumption, organ weights and their
atios data, clinical pathology data including hematology
nd clinical chemistry were analyzed using ProvantisTM
uilt-in statistical tests. All analyses and comparisons were
valuated at the 5% (P ≤ 0.05) level for signiﬁcance. The data
f both groups were subjected to pair-wise comparisons.
efore performing the pair-wise comparison between the
wo groups, data were evaluated for normality and homo-
eneity. During the conduct of these analyses, when the
ata were found to be heterogeneous, suitable transforma-
ions were made by the inbuilt ProvantisTM software and
NOVA was performed before proceeding with pair-wise
ests using Student’s t-test.
. Results
No mortalities or treatment related clinical signs were
bserved during the treatment period. No treatment-
elated changes were observed in food consumption for the
reated group as compared to the control group (Table 3). A
tatistically signiﬁcant decrease in food consumption was
een in treated males during days 1–4 but returned to nor-
al  by days 4–7. The change was considered incidental and
able 3
ummary of food consumption (g/rat/day).
Group Males 
0 mL/kg 10 mL/kg 
Days 1–4 23.97 ± 0.46 22.73 ± 0.83
Days  4–7 23.65 ± 1.10 23.59 ± 0.96
Days  7–11 22.90 ± 0.75 23.31 ± 1.15
Days  11–14 22.68 ± 0.62 22.49 ± 0.48
ll data are presented as mean values ± standard deviations with N = 5.
 Statistically signiﬁcant from the vehicle control group (P ≤ 0.05).not treatment related. No treatment-related changes were
observed in body weights at the tested dose in either sex
during the entire treatment period (Fig. 1).
Data from the hematology, coagulation, and clinical
chemistry analyses performed on day 15 are presented
in Table 4. Statistically signiﬁcant changes in hematology
included increased absolute monocytes in treated males
and increased neutrophils (%) and decreased white blood
cells and absolute lymphocytes in treated females. These
changes were considered incidental due to the minor mag-
nitude of the changes and/or the changes being within
the physiological range (historical control data for the sta-
tistically signiﬁcant parameters are provided in Table 5).
For coagulation parameters, an increase in prothrombin
time (5%) was  seen in treated females and was  consid-
ered an incidental ﬁnding. No other changes in coagulation
parameters were seen. Clinical chemistry values including
blood urea nitrogen (BUN), total protein, inorganic phos-
phorous, calcium, albumin, globulin, and A/G ratio were
statistically different in treated males and/or females when
compared to controls. All of the changes that reached sta-
tistical changes were of a low magnitude and within the
physiological range of the rat model, and therefore were
considered toxicologically insigniﬁcant. No statistically sig-
niﬁcant changes were seen in any of the urine parameters
analyzed in terminally sacriﬁced animals.
When compared to the control groups, no signiﬁ-
cant changes attributed to treatment were seen in organ
weights or organ to body weight ratios for treated males
or females (Tables 6 and 7). A marginal but statistically
signiﬁcant increase in absolute kidney weights was seen
Females
0 mL/kg 10 mL/kg
* 15.29 ± 0.93 15.66 ± 0.47
 15.10 ± 0.75 16.08 ± 0.89
 16.26 ± 1.04 16.40 ± 0.65
 15.88 ± 0.91 15.85 ± 0.43
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Table 4
Summary of hematology, coagulation, and clinical chemistry values on day 15.
Parameter Males Females
0 mL/kg 10 mL/kg 0 mL/kg 10 mL/kg
Hematology
WBC  (109/L) 8.37 ± 1.27 9.22 ± 1.44 7.85 ± 1.30 6.70 ± 1.14*
RBC  (1012/L) 8.39 ± 0.20 8.52 ± 0.29 8.31 ± 0.21 8.22 ± 0.21
HGB  (g/L) 157 ± 5 156 ± 4 156 ± 5 154 ± 4
HCT  (L/L) 0.526 ± 0.011 0.529 ± 0.014 0.514 ± 0.017 0.510 ± 0.015
MCV  (fL) 62.7 ± 0.8 62.1 ± 0.8 61.8 ± 0.9 62.1 ± 1.2
MCH  (pg) 18.7 ± 0.6 18.3 ± 0.5 18.8 ± 0.3 18.7 ± 0.2
MCHC  (g/L) 298 ± 7 295 ± 5 304 ± 4 302 ± 4
Plat  (109/L) 1088 ± 73 1071 ± 91 1036 ± 95 1110 ± 124
Neut  (%) 10.0 ± 3.2 10.8 ± 2.9 7.8 ± 1.3 9.5 ± 1.9*
Lymp  (%) 86.0 ± 3.7 85.0 ± 3.0 87.5 ± 2.8 86.2 ± 2.1
Mono  (%) 1.8 ± 0.5 2.0 ± 0.4 2.5 ± 2.2 2.1 ± 1.6
Eosi  (%) 0.6 ± 0.6 0.6 ± 0.5 0.6 ± 0.2 0.7 ± 0.2
Baso  (%) 0.5 ± 0.3 0.4 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
Neut  A (109/L) 0.81 ± 0.16 1.01 ± 0.34 0.62 ± 0.15 0.65 ± 0.22
Lymp  A (109/L) 7.23 ± 1.34 7.83 ± 1.24 6.85 ± 0.95 5.77 ± 0.97*
Mono  A (109/L) 0.14 ± 0.03 0.18 ± 0.04* 0.22 ± 0.25 0.14 ± 0.08
Eosi  A (109/L) 0.05 ± 0.04 0.05 ± 0.04 0.04 ± 0.01 0.04 ± 0.01
Baso  A (109/L) 0.04 ± 0.03 0.03 ± 0.01 0.03 ± 0.01 0.02 ± 0.01
Coagulation
PT  (s) 16.9 ± 1.2 17.2 ± 0.6 17.7 ± 0.5 18.5 ± 0.6*
APTT  (s) 14.2 ± 2.2 13.7 ± 2.8 12.2 ± 1.5 11.6 ± 2.9
Clinical chemistry
Glu (mmol/L) 7.44 ± 0.73 7.16 ± 0.60 6.87 ± 0.54 7.12 ± 0.32
BUN  (mmol/L) 3.94 ± 0.36 4.58 ± 0.94* 5.92 ± 0.81 5.11 ± 0.65*
Creat  (mol/L) 24 ± 9 21 ± 4 25 ± 8 21 ± 6
AST  (U/L) 93 ± 17 92 ± 11 94 ± 9 94 ± 6
ALT  (U/L) 61 ± 11 55 ± 6 49 ± 6 50 ± 4
GGT  (U/L) 0 ± 1 1 ± 1 2 ± 1 1 ± 1
ALP  (U/L) 177 ± 10 180 ± 16 117 ± 17 120 ± 15
T.  Bil (mol/L) 1.70 ± 0.78a 1.50 ± 0.54 1.25 ± 0.58b 0.91 ± 0.28b
T. Chol (mmol/L) 3.34 ± 0.15 3.41 ± 0.27 3.49 ± 0.17 3.49 ± 0.20
Trig  (mmol/L) 0.74 ± 0.11 0.71 ± 0.08 0.66 ± 0.16 0.59 ± 0.06
T.  Pro (gL) 64.1 ± 1.8 69.4 ± 4.8* 70.8 ± 1.6 66.9 ± 1.2*
Alb  (g/L) 41.0 ± 1.3 40.4 ± 1.2 40.2 ± 2.8 41.7 ± 0.8*
Pi  (mmol/L) 2.95 ± 0.11 2.78 ± 0.19* 2.44 ± 0.17 2.37 ± 0.10
Ca  (mmol/L) 2.47 ± 0.11 2.32 ± 0.11* 2.43 ± 0.21 2.48 ± 0.10
Na  (mEq/L) 149.4 ± 1.7 150.5 ± 0.7 148.4 ± 1.5 149.3 ± 1.8
K  (mEq/L) 3.90 ± 0.21 3.86 ± 0.24 3.47 ± 0.26 3.47 ± 0.21
WBC, white blood corpuscles; RBC, red blood corpuscles; HGB, haematoglobin; HCT, haematocrit; MCV, mean corpuscular volume; MCH, mean corpus-
cular  hemoglobin; MCHC, mean corpuscular hemoglobin concentration; Plat, platelets; Neut, neutrophils; Lymp, lymphocytes; Mono, monocytes; Eosi,
eosinophils; Baso, basophils; PT, prothrombin time; APTT, activated partial thromboplastin time; Glu, glucose; BUN, blood urea nitrogen; Creat, creatine;
AST,  aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma glutamyl transpeptidase; ALP, alkaline phosphatase; T. Bil, total bilirubin; T.
Chol,  total cholesterol; Trig, triglycerides; T. Pro, total plasma protein; Alb, albumin; Pi, inorganic phosphorous; Ca, calcium; Na, sodium; K, potassium.
Data  are presented as mean values ± standard deviations with N = 10.
*  Statistically signiﬁcant from the vehicle control group (P ≤ 0.05).
0 mol
 mol/La N = 8 (two values below the lower limit of Quantiﬁcation for T. Bil (0.4
b N = 9 (one value below the lower limit of Quantiﬁcation for T. Bil (0.40
in treated females (7%). This increase was not statisti-
cally signiﬁcant in relative kidney weights. In addition, no
correlating changes in clinical observations or histopatho-
logical changes were seen. Therefore, the kidney weight
change was considered to be incidental.
Compared to their respective control groups, no test
item-related gross pathological lesions were evident in
male or female rats at terminal necropsy (day 15). No
incidental ﬁndings were seen in females. In treated males
a single incidence of unilateral testis focal reddish dis-
coloration was seen. No correlating changes were seen
microscopically. The discoloration was determined to
be incidental. No other incidental ﬁndings were seen/L) were not considered for analysis).
) was not considered for analysis).
in males. Microscopic ﬁndings (accessory cortical tissue
in adrenal glands, esophageal inﬂammatory foci, cardiac
inﬂammatory focus, renal basophilic or cystic tubules,
hepatocellular inﬂammatory focus, pulmonary inﬂam-
matory focus, pancreatic acinar cell apoptosis, prostate
lymphocytic inﬁltration, spinal cord keratin cyst, stom-
ach dilated gland glandular mucosa, thymus hemorrhage,
inﬂammation or epithelial cyst with eosinophilic crys-
tals, thyroid gland ectopic thymus, and uterine dilation)
occurred at low frequencies in the control and treated ani-
mals and were not considered treatment related (Table 8).
Under the conditions of this study, oral gavage adminis-
tration of viable N. oculata suspension at the dose volume of
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Fig. 1. Periodical body weights of male and female rats administered Nannochlo
(n  = 10/sex/group). The data represent the mean values for each group.
Table 5
Historical control data for statistically signiﬁcant hematology/clinical
chemistry parameters.
Parameter Historical control
values (mean
values)
Historical
control
(ranges)
Hematology and coagulation
Monocyte absolute –
males (G/L)
0.63 0.04–6.60
White blood cells
(WBC) – females
(G/L)
8.44 3.76–13.87
Neutrophil % –
females (%)
8.36 0.67–17.60
Lymphocyte absolute
– females (G/L)
13.18 2.91–83.20
Prothrombin time –
females (s)
16.50 13.20–19.20
Clinical chemistry
Blood urea nitrogen
– males (mmol/L)
4.81 1.97–8.04
Total protein – males
(g/L)
61.93 47.50–72.90
Inorganic
phosphorous – males
(mmol/L)
2.86 2.25–3.70
Calcium – males
(mmol/L)
16.07 2.32–154.30
Blood urea nitrogen
– females (mmol/L)
5.62 3.11–9.18
Total protein –
females (g/L)
64.51 48.00–79.00
Albumin – females
(g/L)
39.56 9.60–60.70
1
a
r
4
s
a
a
pOrgan weights
Kidneys – absolute
wt – females (g)
1.33 0.74–1.97
0 mL/kg (providing at least 1 × 10E8 viable cells) to male
nd female rats for 14 days did not cause any treatment-
elated effects.
. Discussion
Prior to this study, the toxicity of Nannochloropsis
pecies algae has been assessed in rats following acute
nd subchronic (up to 60 days) administration [8–10]
s well as in pregnant rats during mating and through
regnancy and lactation [11]. Acute toxicity tests in ratsropsis oculata or the vehicle control by daily by oral gavage for 14 days
administered biomass of N. oculata by oral gavage revealed
no effects (LD50 ≥ 12 g/kg) [8,9]. Similarly, no treatment-
related effects were seen in rats treated with 3000 or
6000 mg/kg/day N. oculata biomass by oral gavage daily
for 60 days (NOAEL ≥ 6000 mg/kg/day) [8]. However, this
previously conducted study only focused on the potential
nephrotoxicity or hepatotoxicity of a nonviable N. oculata
biomass, not to the potential pathogenicity of the viable
organism. No treatment-related effects were seen in rats
fed 10,000 mg/kg/day whole freeze-dried Nannochloropsis
(species not stated), algal lipid extract (3500 mg/kg/day)
or algal residue (6500 mg/kg/day) daily for 30 days [10].
However, Nuno et al., [9] reported weight loss in hyper-
glycemic male rats treated with a freeze-dried culture of N.
oculata by oral gavage (250 mg/kg/day) daily for 8 weeks.
Examination of intestinal tissue sections revealed the pres-
ence of intestinal atrophy and gastrointestinal damage. The
authors noted that the adverse effects may  have been due
to the algae’s cellular structure, as the cell wall of N. ocu-
lata is rigid and relatively thick, and when freeze-dried
could adversely impact the epithelium, lactic acid bacte-
ria counts, and nutrient absorption [9]. No reproductive
or developmental effects were seen following the treat-
ment of pregnant and lactating rats with 2000 mg/kg/day
Nannochloropsis algae in the diet [11].
Here we  describe the nonclinical toxicity of viable N.
oculata in rats following daily administration in rats by
oral gavage for 14 days. No treatment-related effects were
seen in male or female rats following daily oral treatment
with 10 mL/kg, providing at least 1 × 10E8 viable algal cells
to each animal. A transient decrease in food consumption
occurred at days 1–4 in the male rats, but returned to the
control range for the remainder of the study. Non-viable
N. oculata biomass has been provided to Sprague-Dawley
rats for 60 days with signiﬁcant increases in body weight
gains, compared to control rats [8]. However, it was  not
stated that the diets in this study were isocaloric. Sta-
tistically signiﬁcant changes seen in the hematological
parameters were not indicative of a response to infec-
tion, as the changes were both increased (i.e., absolute
monocytes in the males and increased neutrophils in the
females) and decreased (i.e., white blood cells and absolute
lymphocytes), and were minor in magnitude. In the same
manner, the clinical chemistry value changes that reached
signiﬁcance were not consistent between the male and
622 M.L. Kagan, R.A. Matulka / Toxicology Reports 2 (2015) 617–623
Table 6
Summary of terminal fasting body weights and absolute organ weights on day 15.
Group Males Females
0 mL/kg 10 mL/kg 0 mL/kg 10 mL/kg
Terminal fasting BW (g) 242.47 ± 7.85 241.55 ± 8.90 175.73 ± 11.93 179.52 ± 8.19
Adrenals (g) 0.0494 ± 0.0057 0.0504 ± 0.0050 0.0635 ± 0.0039 0.0635 ± 0.0063
Brain  (g) 1.7788 ± 0.0721 1.7615 ± 0.0479 1.6966 ± 0.0495 1.6655 ± 0.0635
Epididymides (g) 0.7626 ± 0.0656 0.7815 ± 0.0693 – –
Heart  (g) 0.9614 ± 0.0661 0.9400 ± 0.0542 0.7365 ± 0.0728 0.7516 ± 0.0689
Kidneys (g) 1.7076 ± 0.1248 1.7031 ± 0.1289 1.1664 ± 0.0970 1.2517 ± 0.0825*
Liver  (g) 7.8023 ± 0.6408 7.9786 ± 0.3449 5.7662 ± 0.6303 5.8339 ± 0.4218
Ovaries – – 0.0829 ± 0.0151 0.0903 ± 0.0123
Pituitary (g) 0.0106 ± 0.0011 0.0102 ± 0.0009 0.0119 ± 0.0016 0.0123 ± 0.0009
Prostate (g) 0.6334 ± 0.1241 0.6051 ± 0.0892 – –
Seminal vesicles & coagulating glands (g) 0.9122 ± 0.1593 0.9074 ± 0.1118 – –
Spleen  (g) 0.6686 ± 0.0491 0.6749 ± 0.0606 0.5584 ± 0.0940 0.5802 ± 0.0760
Testes (g) 3.2168 ± 0.1936 3.2735 ± 0.2095 – –
Thymus (g) 0.5265 ± 0.0494 0.5356 ± 0.0921 0.4463 ± 0.1134 0.4184 ± 0.1130
Thyroid with parathyroids (g) 0.0287 ± 0.0060 0.0299 ± 0.0049 0.0268 ± 0.0060 0.0249 ± 0.0029
Uterus with cervix (g) – – 0.4234 ± 0.0523 0.5206 ± 0.2208All data are presented as mean values ± standard deviations with N = 10.
*  Statistically signiﬁcant from the vehicle control group (P ≤ 0.05).
female groups, were within the physiological range of the
Sprague-Dawley rat for the laboratory, and did not corre-
late with any histological changes in the organs. This is the
ﬁrst known study which evaluated the potential toxicity or
pathogenicity of the microalgae N. oculata.  Other microal-
gae are known to produce algal toxins that can cause animal
and human toxicity. Administration of the viable N. oculata
cells shows that this species of microalgae does not pro-
duce toxins that hinder the growth of this rat model when
consumed over a 14-day period.
Because it is a rich source of eicosapentaeneoic acid
(EPA), the microalgae N. oculata is being utilized in the
production of Almega PLTM (Qualitas Health, Ltd.), an
EPA-rich omega-3 oil isolated for use as a dietary sup-
plement ingredient. In addition to the 14-day study on
N oculata presented here, a battery of nonclinical stud-
ies indicating the safety of the algal oil at levels up
Table 7
Summary of organ to body weight ratios on day 15.
Group Males 
0 mL/kg 10
Adrenals (%) 0.0204 ± 0.0027 0
Brain  (%) 0.7337 ± 0.0219 0
Epididymides (%) 0.3151 ± 0.0320 0
Heart  (%) 0.3968 ± 0.0287 0
Kidneys (%) 0.7040 ± 0.0405 0
Liver  (%) 3.2141 ± 0.1737 3
Ovaries (%) – 
Pituitary (%) 0.0044 ± 0.0005 0
Prostate (%) 0.2612 ± 0.0498 0
Seminal vesicles & coagulating glands (%) 0.3770 ± 0.0698 0
Spleen  (%) 0.2757 ± 0.0180 0
Testes (%) 1.3264 ± 0.0606 1
Thymus (%) 0.2169 ± 0.0163 0
Thyroid with parathyroids (%) 0.0118 ± 0.0025 0
Uterus with cervix (%) – 
All data are presented as mean values ± standard deviations with N = 10.
*  Statistically signiﬁcant from the vehicle control group (P ≤ 0.05).to 2000 mg/kg/day has recently been published [12]. As
shown in several published preclinical studies, consump-
tion of N. oculata biomass for up to 60 days did not cause
any adverse effects. However, one study did indicate that
gavage administration of freeze-dried N. oculata biomass
caused gastrointestinal damage most likely due to the rigid
cell wall of N. oculata.  Because EPA supplements derived
from N oculata would consist of oil extracted from the algae,
and not the algae itself, the rigid cell wall would not be a
safety issue.
In conclusion, treatment with viable N. oculata sus-
pension at a dose volume of 10 mL/kg (providing at least
1 × 10E8 viable algal cells/animal) to male and female rats
for 14 days did not cause any treatment-related effects.
Based on the available data, N. oculata used in the devel-
opment of an EPA-delivering dietary supplement is not
toxigenic or pathogenic when administered orally to rats.
Females
 mL/kg 0 mL/kg 10 mL/kg
.0209 ± 0.0025 0.0363 ± 0.0033 0.0354 ± 0.0037
.7300 ± 0.0289 0.9704 ± 0.0846 0.9301 ± 0.0660
.3235 ± 0.0242 – –
.3892 ± 0.0177 0.4186 ± 0.0208 0.4181 ± 0.0249
.7053 ± 0.0495 0.6646 ± 0.0469 0.6985 ± 0.0520
.3056 ± 0.1533 3.2772 ± 0.2061 3.2481 ± 0.1504
– 0.0473 ± 0.0091 0.0504 ± 0.0075
.0042 ± 0.0004 0.0068 ± 0.0009 0.0069 ± 0.0006
.2500 ± 0.0315 – –
.3761 ± 0.0481 – –
.2794 ± 0.0236 0.3161 ± 0.0350 0.3227 ± 0.0340
.3562 ± 0.0903 – –
.2216 ± 0.0370 0.2521 ± 0.0500 0.2311 ± 0.0524
.0124 ± 0.0019 0.0152 ± 0.0031 0.0139 ± 0.0017
– 0.2419 ± 0.0323 0.2909 ± 0.1259
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Table  8
Summary of histopathological ﬁndings for male and female rats following exposure to Nannochloropsis oculata for 14 days.
Group Males Females
0 mL/kg 10 mL/kg 0 mL/kg 10 mL/kg
Number of animals per group 10 10 10 10
Adrenal glands
Accessory cortical tissue 0 0 0 1
Esophagus
Inﬂammatory focus; muscularis (minimal) 0 1 1 1
Heart
Inﬂammatory focus (minimal) 0 1 0 0
Kidneys
Basophilic tubules (minimal) 2 1 0 0
Cystic  tubule – solitary 0 0 1 0
Liver
Inﬂammatory focus (minimal) 0 1 0 0
Lungs
Inﬂammatory focus (minimal) 0 0 0 1
Pancreas
Increased acinar cell apoptosis (minimal) 2 1 0 0
Pituitary gland
Cyst; pars distalis 0 0 1 0
Prostate
Lymphocytic inﬁltration (minimal) 2 1 – –
Rectum
Nematode 1 0 0 0
Spinal  cord
Keratin cyst 0 0 0 1
Stomach
Dilated gland – solitory; glandular mucosa 0 0 0 1
Thymus
Hemorrhage (minimal) 0 0 0 1
Inﬂammation (mild) 0 0 0 1
Epithelial cysts with eosinophilic crystals 1 1 2 1
Thyroid gland
Ectopic thymus 0 2 1 0
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Dilation (mild) – 
ll data are presented as number of animals affected.
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